Synonym:
4,4′-(1H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile,
Letrozole
Properties:
Related Categories |
Additional Standards,
Analytical Standards,
Analytical/Chromatography,
Chromatography,
Pharmaceutical Secondary Standards,
|
grade
|
certified reference material
|
|
pharmaceutical secondary standard
|
InChI Key
|
HPJKCIUCZWXJDR-UHFFFAOYSA-N
|
form
|
solid
|
packaging
|
pkg of 1 g
|
pharmacopeia traceability
|
traceable to PhEur Y0000685
|
|
traceable to USP 1356971
|
Description:
Analysis Note
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
General description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Other Notes
This product was designed, produced and verified for accuracy and stability in accordance with ISO/IEC 17025:2005 (AClass Cert AT-1467), ISO GUIDES 34:2009 (AClass Cert AR-1470).
Biochem/physiol Actions
Letrozole is a third generation nonsteroidal aromatase inhibitor. It is a competitive inhibitor of the aromatase enzyme system and thus inhibits the conversion of androgens to estrogens. Letrozole inhibits the aromatase enzyme by competitively binding to the heme of the cytochrome P450 subunit of the enzyme, resulting in a reduction of estrogen biosynthesis in all tissues.
Footnote
To see an example of a Certificate of Analysis for this material enter LRAA4186 in the slot below. This is an example certificate only and may not be the lot that you receive.
Safety:
RIDADR
NONH for all modes of transport